levcromakalim
- Generic Name
- levcromakalim
The Effect of Levcromakalim Infusion on the Cranial Arteries Over Several Hours Using a High Resolution MRA Technique in a Randomized, Double-blind Placebo-controlled Design in Healthy Volunteers.
Not Applicable
Completed
- Conditions
- Dilatation of Cranial Arteries; MMA, STA and MCAHeadache
- Interventions
- Drug: Saline
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2022-07-05
- Lead Sponsor
- Danish Headache Center
- Target Recruit Count
- 20
- Registration Number
- NCT03609008
- Locations
- 🇩🇰
Danish headache center, Copenhagen, Glostrup, Denmark
Headache Inducing Effect of Cromakalim in Migraine Patients
- First Posted Date
- 2017-07-24
- Last Posted Date
- 2018-06-19
- Lead Sponsor
- Danish Headache Center
- Target Recruit Count
- 16
- Registration Number
- NCT03228355
- Locations
- 🇩🇰
Danish headache center, Copenhagen, Glostrup, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath